ObsEva (NASDAQ:OBSV) Coverage Initiated by Analysts at StockNews.com

Equities researchers at StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Sunday. The firm set a “hold” rating on the stock.

ObsEva Price Performance

OBSV stock opened at $0.01 on Friday. ObsEva has a 1-year low of $0.08 and a 1-year high of $2.14. The company has a market capitalization of $389,855.00, a price-to-earnings ratio of -0.01 and a beta of 0.68. The business has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.04.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.